Armistice Capital, LLC 13D and 13G filings for Brainstorm Cell Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:25 pm Sale |
2024-12-31 | 13G | Brainstorm Cell Therapeutics Inc. BCLI |
Armistice Capital, LLC | 299,548 4.990% |
-7,784,398 (-96.29%) |
Filing |
| 2024-11-14 3:24 pm Purchase |
2024-09-30 | 13G | Brainstorm Cell Therapeutics Inc. BCLI |
Armistice Capital, LLC | 8,083,946 9.990% |
8,083,946 (New Position) |
Filing |